COST-EFFECTIVENESS OF TORACOTOMY VERSUS VIDEOTORACOSCOPY IN PATIENTS WITH NON-SMALL CELL LUNG CANCER IN STADIUM

被引：0
|
作者：
Guevara, G. A. [1 ]
Parody, E. [1 ]
Aguirre, A. F. [2 ]
机构：
[1] Icesi Univ, Cali, Colombia
[2] Ctr Social Protect & Hlth Econ, Cali, Colombia
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN34
引用
收藏
页码：A821 / A821
页数：1
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS OF PEMETREXED IN FIRST LINE TREATMENT OF NON-SMALL CELL LUNG CANCER IN PORTUGAL
    Pinto, C. G.
    Manacas, M.
    Miguel, L. S.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A222 - A222
  • [32] Cost-effectiveness of immune checkpoint inhibitors and radiotherapy in advanced non-small cell lung cancer
    Giuliani, Jacopo
    Fiorica, Francesco
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (08) : 2004 - 2006
  • [33] Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer
    Witlox, Willem J. A.
    Ramaekers, Bram L. T.
    Lacas, Benjamin
    Le Pechoux, Cecile
    Sun, Alexander
    Wang, Si-Yu
    Hu, Chen
    Redman, Mary
    van der Noort, Vincent
    Li, Ning
    Guckenberger, Matthias
    van Tinteren, Harm
    Hendriks, Lizza E. L.
    Groen, Harry J. M.
    Joore, Manuela A.
    De Ruysscher, Dirk K. M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 170 : 95 - 101
  • [34] Cost-effectiveness of first-line immunotherapies for advanced non-small cell lung cancer
    Yang, Szu-Chun
    Ou, Huang-Tz
    Su, Wu-Chou
    Wang, Shi-Yi
    [J]. CANCER MEDICINE, 2023, 12 (07): : 8838 - 8850
  • [35] Cost-Effectiveness of Immune Checkpoint Inhibitors in the Treatment of Advanced Non-Small Cell Lung Cancer
    Kuhlmann, A.
    Schmidt, T.
    Treskova, M.
    Golpon, H.
    Welte, T.
    Von der Schulenburg, J. -Graf
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2302 - S2303
  • [36] Cost-Effectiveness Analysis of Robotic-assisted Lobectomy for Non-Small Cell Lung Cancer
    Heiden, Brendan T.
    Mitchell, Joshua D.
    Rome, Eric
    Puri, Varun
    Meyers, Bryan F.
    Chang, Su-Hsin
    Kozower, Benjamin D.
    [J]. ANNALS OF THORACIC SURGERY, 2022, 114 (01): : 265 - 272
  • [37] A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer
    Lange, A.
    Prenzler, A.
    Frank, M.
    Golpon, H.
    von der Schulenburg, Graf J-M
    [J]. ONKOLOGIE, 2013, 36 : 251 - 251
  • [38] International Cost-Effectiveness Analysis of Durvalumab in Stage III Non-Small Cell Lung Cancer
    Kareff, Samuel A.
    Han, Sunwoo
    Haaland, Benjamin
    Jani, Chinmay J.
    Kohli, Rhea
    Aguiar Jr, Pedro Nazareth
    Huang, Yiqing
    Soo, Ross A.
    Rodriguez-Perez, Angel
    Garcia-Foncillas, Jesus
    Domine, Manuel
    de Lima Lopes, Gilberto
    [J]. JAMA NETWORK OPEN, 2024, 7 (05)
  • [39] COST-EFFECTIVENESS ANALYSIS OF EGFR MUTATION TEST FOR NON-SMALL CELL LUNG CANCER IN CHINA
    Jin, G.
    Yang, L.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A247 - A247
  • [40] Dosimetry, Efficacy, Safety, and Cost-Effectiveness of Proton Therapy for Non-Small Cell Lung Cancer
    Qiu, Bin
    Men, Yu
    Wang, Junjie
    Hui, Zhouguang
    [J]. CANCERS, 2021, 13 (18)
12345